3 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 2 | Terminated 2 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nabilone for Agitation in Frontotemporal Dementia Nabilone, Placebo - Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant | Phase 2 | Terminated | Simon Ducharme, MD | 3 | 2023-03-07 | 2026-07-28 |
| Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia Famotidine, Speech Language Therapy - Laryngomalacia, Gastro Esophageal Reflux | Phase 1 / Phase 2 | Terminated | Reema Padia | 65 | 2020-11-18 | 2025-07-20 |
| Evaluating Anodal tDCS Preceding Aphasia Therapy transcranial direct current stimulation - Stroke, Aphasia | Phase 1 / Phase 2 | Terminated | Northwell Health | 15 | 2014-09-01 | 2021-04-05 |
Aphasia (1) · Aphasia, Primary Progressive (1) · Apraxias (1) · Dementia (1) · Frontotemporal Dementia (1) · Gastroesophageal Reflux (1) · Laryngomalacia (1) · Pick Disease of the Brain (1) · Psychomotor Agitation (1) · Stroke (1)
Mental Disorders (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Language Disorders (2) · Neurodevelopmental Disorders (2) · Psychomotor Disorders (2) · Speech Disorders (2) · Aberrant Motor Behavior in Dementia (1) · Aphasia (1) · Behavior (1)
Famotidine (1) · Speech Therapy (1) · Transcranial Direct Current Stimulation (1) · nabilone (1)
Northwell Health (1) · Reema Padia (1) · Simon Ducharme, MD (1)
United States (2) · Canada (1)
Reema Padia, MD (1)